Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2018 16:05 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Host Conference Call of Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 7, 2018

BOSTON, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today...
December 22, 2017 09:05 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Webcast its Presentation at J.P. Morgan’s 36th Annual Healthcare Conference on January 10, 2018

BOSTON, Dec. 22, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today...
November 08, 2017 16:16 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in November 2017

BOSTON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today...
November 07, 2017 07:01 ET | Source: Keryx Biopharmaceuticals, Inc.

U.S. FDA Approves Auryxia® (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis

Auryxia is the only oral treatment option available today developed and approved specifically for adults living with iron deficiency anemia and chronic kidney disease, not on dialysisOne in seven...
November 07, 2017 07:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Third Quarter 2017 Financial Results

Company reported $15.0 million in third quarter 2017 total revenues, including net U.S. Auryxia® product sales of $13.6 millionU.S. Food and Drug Administration (FDA) approves Auryxia® (ferric...
November 06, 2017 16:31 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Moves Third Quarter 2017 Financial Results Call to Tuesday, November 7, 2017 at 8:00 a.m. ET

BOSTON, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today...
November 04, 2017 11:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Presentation of Real World Dialysis Data of Auryxia® at ASN’s 2017 Kidney Week

NEW ORLEANS, Nov. 04, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today presented new...
November 02, 2017 18:55 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia® (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease

Oral presentation showed impact of ferric citrate on a phosphate-regulating hormone, FGF23Poster presentation showed effect of ferric citrate when dosed to increase hemoglobin on serum phosphorus in...
October 26, 2017 16:15 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2017 Financial Results on Monday, November 6, 2017

BOSTON, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today...
October 13, 2017 10:10 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Presentations of New Data at the American Society of Nephrology Kidney Week 2017 Annual Meeting

BOSTON, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a company focused on bringing innovative medicines to people with kidney disease, today announced that three...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right